| Data | Hora | Fonte | Título | Código | Companhia |
| 26/10/2021 | 07:59 | Business Wire | Crestwood to Acquire Oasis Midstream Partners in $1.8 Billion Transaction | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 25/04/2013 | 09:00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 24/04/2013 | 09:00 | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 23/04/2013 | 09:00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstand... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 22/04/2013 | 09:00 | PR Newswire (US) | Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisitio... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 17/04/2013 | 17:28 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 18:30 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 18:17 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 12/04/2013 | 18:17 | Edgar (US Regulatory) | Post-effective Amendment (investment Company, Rule 485(a)) (485apos) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 09/04/2013 | 11:43 | Zacks | Valeant: The Sole Suitor for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 10:20 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 09:22 | Dow Jones News | Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 08/04/2013 | 08:32 | PR Newswire (US) | Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 14:50 | Zacks | Valeant Ups Offer for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 15:51 | GlobeNewswire Inc. | CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 14:47 | GlobeNewswire Inc. | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medic | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 12:26 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 10:02 | Dow Jones News | Valeant Boosts Price for Obagi to $420 Million, Besting Merz Offer | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 09:00 | PR Newswire (US) | Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 03/04/2013 | 09:00 | Business Wire | Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 17:22 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 14:42 | Dow Jones News | UPDATE: Merz Pharma Offers to Buy Obagi, Looks to Top Valeant Deal | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 13:30 | Business Wire | Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 09:44 | Dow Jones News | Merz Pharma Offers to Buy Obagi, Looks to Top Valeant Deal | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 02/04/2013 | 08:37 | PR Newswire (US) | Merz Pharma Group Makes Superior Proposal to Acquire Obagi Medical Products | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 28/03/2013 | 17:48 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 27/03/2013 | 14:12 | PR Newswire (US) | Rigrodsky & Long, P.A. Announces Investigation Of Obagi Medical Products, Inc. Buyout | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 26/03/2013 | 18:17 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 26/03/2013 | 18:15 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 26/03/2013 | 13:28 | Business Wire | ATTENTION SHAREHOLDERS: Obagi Medical Products, Inc. (OMPI) Board of Directors Investigated by The Young Law Firm for Possibl... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |